Last Modified: August 11, 2002
Conference Dates: October 17 - 18, 2002
Conference Location: Atlanta, Georgia, USA
Sponsoring Group: Imedex, Inc.
Conference Web Page URL: www.imedex.com/announcements/breast02.html
Topics Covered: Breast Cancer Biology, Screening and Diagnosis, DCIS and Early Breast Cancer, DCIS and Early Breast Cancer, Systemic Therapies, New Targeted Approaches
Conference Objectives: After successfully completing this educational program, participants should be able to:
Who Should Attend: This educational program is intended for physicians in active clinical practice who are interested and/or involved in the management of patients with breast cancer. No specialized knowledge or skills other than a general familiarity with cancer and its treatment is required for successful participation in this program.
Registration Information: Online: www.imedex.com, Fax: 770-751-7334, Telephone: 770-751-7332, Mail: Imedex, Inc. 70 Technology Drive, Alpharetta, GA 30005
Conference Fees: $225 by August 12; $325 by October 11; $425 after October 11
Continuing Education: Yes
Miscellany: Imedex USA, Inc. is accredited by the Accreditation Council for Continuing Medical Education to provide continuing medical education for physicians. Imedex USA, Inc. designates this continuing medical education activity for up to 13.5 credit hours in Category 1 of the Physician's Recognition. Each participant should claim only those hours of credit that he/she actually spent in the educational activity.
Nov 12, 2010 - Alongside a steep decline in the use of hormone therapy, incidence of invasive breast cancer and ductal carcinoma in situ fell in older women undergoing regular mammography in 2002 to 2006, according to research published online Nov. 8 in the Journal of Clinical Oncology.
Nov 12, 2010
Sep 26, 2011
Mar 2, 2011
Feb 20, 2012